A new freezing and storage procedure improves safety and viability of haematopoietic stem cells and neutrophil engraftment: A single institution experience

Vox Sanguinis

Volumn 98, Issue 2, 2010, Pages 172-180

  Abbruzzese, L ^a   Michieli, M ^a   Rupolo, M ^a   Toffola, R Tassan ^a   Da Ponte, A ^a   Rossi, F M ^a   Lorenzon, D ^a   Simonelli, C ^a   Gattei, V ^a   De Marco, L ^a   Mazzucato, M ^a  

^a CRO National Cancer Institute IRCCS Aviano   (Italy)

Author keywords

Cryopreservation; Safety; Stem cell; Transplantation

Indexed keywords

CARMUSTINE; CYTARABINE; ETOPOSIDE; MELPHALAN; NITROGEN;

ADULT; AGED; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CELL VIABILITY; CRYOTHERAPY; ENGRAFTMENT; EWING SARCOMA; FREEZING; GAS; HEMATOPOIETIC STEM CELL; HODGKIN DISEASE; HUMAN; LIQUID; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; NEUTROPHIL ENGRAFTMENT; NONHODGKIN LYMPHOMA; OBSERVATIONAL STUDY; PATIENT SAFETY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STORAGE; TANK; THAWING; AUTOTRANSPLANTATION; BLOOD STORAGE; CELL COUNT; CELL SEPARATION; CRYOPRESERVATION; PACKAGING; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROCEDURES; SAFETY;

BLOOD PRESERVATION; CELL COUNT; CELL SEPARATION; CRYOPRESERVATION; FREEZING; HEMATOPOIETIC STEM CELLS; HUMANS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRODUCT PACKAGING; SAFETY; TRANSPLANTATION, AUTOLOGOUS;

EID: 74549157753     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2009.01239.x     Document Type: Article

References (31)

1. Gabarre J, Leblond V, Sutton L, Azar N, Jouan M, Boccaccio C, Gonzales H, Charlotte F, Gentilini M, Binet JL : Autologous bone marrow transplantation in relapsed HIV-related non-Hodgkin's linphoma. Bone Marrow Transplant 1996 18 : 1195 1197.
2. Molina A, Krishnan AY, Nademanee A, Zabner R, Sniecinski I, Zaia J, Forman SJ : High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy. Cancer 2000 89 : 680 689.
3. Molina A, Zaia J, Krishnan AY : Treatment of human immunodeficiency virus-related lymphoma with haematopoietic stem cell transplantation. Blood Rev 2003 17 : 249 258.
4. Fountain D, Ralston M, Higgins M, Gorlin JB, Uhl L, Wheeler C, Antin JH, Churchill WH, Benjamin RJ. : Liquid nitrogen freezers: a potential source of microbial contamination of hematopoietic stem cell components. Transfusion 1997 37 : 585 591.
5. Morris GJ : The origin, ultrastructure, and microbiology of the sediment accumulating in liquid nitrogen storage vessels. Cryobiology 2005 50 : 231 238.
6. Farrington M, Matthews I, Marcus R, Scott MA, Caffrey E, Hunt CJ : Contamination of bone marrow transplants from peripheral blood. BMJ 1994 309 : 958.
7. Rollig C, Babatz J, Wagner I, Maiwald A, Schwarze V, Ehninger G, Bornhauser M. : Thawing of cryopreserved mobilized peripheral blood - comparison between waterbath and dry warming device. Cytotherapy 2002 4 : 551 555.
8. Espinosa MTF, Fox R, Creger RJ, Lazarus HM : Microbiologic contamination of peripheral blood progenitor cells collected for hematopoietic cell transplantation. Transfusion 1996 36 : 789 793.
9. Webb IJ, Coral FS, Andersen JW, Elias AD, Finberg RW, Nadler LM, Ritz J, Anderson KC. : Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering. Transfusion 1996 36 : 782 788.
10. Husebekk A, Skaug K, Kolstad A, Dahl IMS, Guttemberg T, Skogen B : Hepatitis B virus-infected peripheral blood progenitor cell harvests in liquid nitrogen freezer containing non-infectious products. Transfusion 2004 44 : 942 943.
11. Padley D, Koontz F, Trigg ME, Gingrich R, Strauss RG : Bacterial contamination rates following processing of bone marrow and peripheral blood progenitor cell preparations. Transfusion 1996 36 : 53 56.
12. Koka PS, Jamieson BD, Brooks DG, Zack JA : Human immunodeficiency virus type 1-induced hematopoietic inhibition is independent of productive infection of progenitor cells in vivo. J Virol 1999 73 : 9089 9097.
13. Schooley RT, Mladenovic J, Sevin A, Chiu S, Miles SA, Pomerantz RJ, Campbell TB, Bell D, Ambruso D, Wong R, Landay A, Coombs RW, Fox L, Kamoun M, Jacovini J. : Reduced mobilization of CD34+ stem cells in advanced human immunodeficiency virus type 1 disease. J Infect Dis 2000 181 : 148 157.
14. Abrahamsen JF, Bakken AM, Bruserud O : Cryopreserving human peripheral blood progenitor cells with 5-percent rather than 10-percent DMSO results in less apoptosis and necrosis in CD34+ cells. Transfusion 2002 42 : 1573 1580.
15. Lecchi L, Giovanelli S, Musacchio L, Rebulla P : Development of a mock hemopoietic stem cell component suitable for the validation of cryopreservation procedures. Transfus Apher Sci 2006 34 : 299 307.
16. Keeney M, Chin-Yee I, Weir K, Popma J, Nayar R, Sutherland DR : Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering. Cytometry 1998 34 : 61 70.
17. Khuu HM, Cowley H, David-Ocampo V, Carter CS : Catastrophic failures of freezing bags for cellular therapy products: description,cause, and consequences. Cytotherapy 2002 4 : 539 549.
18. Mele L, Dallavalle FM, Verri MG, Balza G, Allione B, Salvi F, Levis A, Caraccio V, Borzini P : Safety control of peripheral blood progenitor cell processing-eight year-survey of microbiological contamination and bag ruptures in a single institution. Transfus Apher Sci 2005 33 : 269 274.
19. Armitage P, Berry G : Statistical Methods in Medical Research. Boston, MA, 1987
20. Rowley SD, Bensinger WI, Gooley TA, Buckner CD : Effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation. Blood 1994 83 : 2731 2736.
21. Jones R, Nieto Y, Rizzo JD, Wall D, Wingard JR, McCarthy J, McCarthy P Jr., Hahn T : The evolution of the evidence-based review: evaluating the science enhances the art of medicine - statement of the Steering Committee for Evidence-Based Reviews of the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2005 11 : 819 822.
22. Warkentin PI : Voluntary accreditation of cellular therapies: Foundation for the Accreditation of Cellular Therapy (FACT). Cytotherapy 2003 5 : 299 305.
23. Weaver CH, Hazelton B, Birch R, Palmer P, Allen C, Schwartzberg L, West W. : An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 1995 86 : 3961 3969.
24. Bensinger W, Appelbaum F, Rowley S, Storb R, Sanders J, Lilleby K, Gooley T, Demirer T, Schiffman K, Weaver C, Clift R, Chauncey T, Klarnet J, Montgomery P, Petersdorf S, Weiden P, Witherspoon R, Buckner CD : Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 1995 13 : 2547 2555.
25. Abrahamsen JF, Wentzel-Larsen T, Bruserud O : Autologous transplantation: the viable transplanted CD34+ cell dose measured post-thaw does not predict engraftment kinetics better than the total CD34+ cell dose measured pre-freeze in patients that receive more than 2x10(6) CD34+ cells/kg. Cytotherapy 2004 6 : 356 362.
26. Abrahamsen JF, Rusten L, Bakken AM, Bruserud O : Better preservation of early hematopoietic progenitor cells when human peripheral blood progenitor cells are cryopreserved with 5 percent dimethylsulfoxide instead of 10 percent dimethylsulfoxide. Transfusion 2004 44 : 785 789.
27. Bakken AM : Cryopreserving human peripheral blood progenitor cells. Curr Stem Cell Res Ther 2006 1 : 47 54.
28. Wolfe J, Bryant G : Cellular cryobiology: thermodynamic and mechanical effects. Int J Refrigeration 2001 24 : 438 450.
29. Yoon YH, Pope JM, Wolfe J: The effects of solutes on the freezing properties of and hydration forces in lipid lamellar phases. Biophys J 1998 74 : 1949 1965.
30. Schafer TW, Everett J, Silver GH, Came PE : Biohazard: virus-contaminated liquid nitrogen. Science 1976 191 : 24 26.
31. Watts MJ, Ings SJ, Flynn M, Dodds D, Goldstone AH, Linch DC : Remobilization of patients who fail to achieve minimal progenitor thresholds at the first attempt is clinically worthwhile. Br J Haematol 2000 111 : 287 291.